Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLC12A9 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | PLEKHG4B | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | EMC6 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | ENKUR | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | MYO16 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | CCDC166 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | MICA | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | KRTAP6-3 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | MOGAT1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | AL513122.2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |